CovidResearchTrials by Shray Alag

CovidResearchTrials Covid 19 Research using Clinical Trials (Home Page)

Thoracic CT ScanWiki

Developed by Shray Alag
Clinical Trial MeSH HPO Drug Gene SNP Protein Mutation


Correlated Drug Terms (0)

Name (Synonyms) Correlation

Correlated MeSH Terms (2)

Name (Synonyms) Correlation
D014808 Vitamin D Deficiency NIH 0.45
D018352 Coronavirus Infections NIH 0.04

Correlated HPO Terms (1)

Name (Synonyms) Correlation
HP:0100512 Low levels of vitamin D HPO 0.45

There is one clinical trial.

Clinical Trials

1 Multicentric Retrospective Observational Study of Thoracic Scanner Performance in COVID Screening. Comparison to Virological Testing and Multiparametric Gold Standard

All patients included in this search will be on anonymized file: Symptomatic patients consulting for suspicion of COVID 19 with indication to a screening (RT-PCR, Scanner) according to the criteria of the Ministry of Health. To evaluate the diagnostic performance of chest CT in screening for COVID-related lung injury in patients with a clinical suspicion of COVID. CT scan results for COVID according to French thoracic imaging society will be dichotomized into evocative or compatible (considered positive) non-evocative (considered negative) The results will be compared to the gold standard corresponding to a multiparametric element: the discharge summary. Ct Scan performance will be recorded and analyzed.

NCT04339686 The Gold Standard for Current SARS CoV2 Detection is RT-PCR Diagnostic Test: Thoracic CT Scan

Primary Outcomes

Description: CT Report will dichotomized into evocative or non-evocative for COVID-related lung injury.

Measure: Diagnostic performance of chest CT in screening for pulmonary lesions in clinical suspicions of COVID.

Time: 1 month

Secondary Outcomes

Description: Initial virological RT-PCR results: positive or negative depending on the laboratories of the institutions. Scanner results according to French Thoracic Imaging Society.

Measure: Compare the diagnostic performance of chest CT and RT-PCR in COVID 19 at the initial consultation (screening).

Time: 1 month

No related HPO nodes (Using clinical trials)